Effects of gnRH agonist alone (solid lines) versus gnRH agonist plus low-dose estrogen-progestin add-back (dotted line) on surgical staging scores as determined by pre-treatment and post- treatment laparoscopic surgery

Both the GnRH-agonist alone, and the GnRH agonist plus low dose estrogen-progestin add-back produced similar reductions in implant scores.

RAFS: Revised American Fertility Society scoring system; ADI: additive diameter of implants score.

Reproduced with permission from: Howell R, Edmonds D, Dowsett M. Gonadotropin releasing hormone analogue plus hormone replacement therapy for the treatment of endometriosis: a randomized clinical trial. Fertil Steril 1995; 64:474. Copyright © 1995 American Society for Reproductive Medicine.

Graphic 66544 Version 2.0

خرید پکیج

Effects of gnRH agonist alone (solid lines) versus gnRH agonist plus low-dose estrogen-progestin add-back (dotted line) on surgical staging scores as determined by pre-treatment and post- treatment laparoscopic surgery